# Efficacy of Low-Dose Intravenous Immunoglobulin Combined With Immunosuppression Modification in the Treatment of BK Polyomavirus Nephropathy: A Case Series

## TL;DR

This paper reports on the use of low-dose IVIg in treating BK virus nephropathy in kidney transplant patients, suggesting it may help prevent kidney function decline.

## Contribution

The study introduces low-dose IVIg as a potential treatment for BK polyomavirus nephropathy in renal transplant recipients.

## Key findings

- Low-dose IVIg was used in six renal transplant recipients with BK polyomavirus nephropathy.
- The treatment showed promise in preventing a decline in renal function and graft loss.

## Abstract

New and powerful immunosuppression agents presently available for maintenance immunosuppression and for the treatment of acute and chronic rejection in renal transplantation have led to the emergence of opportunistic infections. One such infection is BK virus nephropathy, leading to graft dysfunction and graft loss. Apart from the reduction and manipulation of immunosuppressive medications, various treatment options such as intravenous immunoglobulin (IVIg), cidofovir, leflunomide, and fluoroquinolones have been tried to treat BK virus nephropathy. We report our experience with low-dose IVIg in six renal transplant recipients with BK polyomavirus nephropathy. We suggest that low-dose IVIg can be a promising treatment option to treat and prevent a decline in renal function and subsequent graft loss.